Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
163.02
+0.77 (0.47%)
At close: Feb 21, 2025, 4:00 PM
165.15
+2.13 (1.31%)
After-hours: Feb 21, 2025, 7:24 PM EST
CRL Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for CRL stock have an average target of 194.62, with a low estimate of 151 and a high estimate of 250. The average target predicts an increase of 19.38% from the current stock price of 163.02.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for CRL stock from 15 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 2 | 0 | 0 | 0 | 0 | 0 |
Hold | 9 | 10 | 9 | 9 | 11 | 11 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 2 | 2 | 2 | 2 | 2 |
Total | 13 | 14 | 13 | 13 | 15 | 15 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JP Morgan | JP Morgan | Hold Maintains $175 → $165 | Hold | Maintains | $175 → $165 | +1.21% | Feb 20, 2025 |
Baird | Baird | Hold Maintains $177 → $173 | Hold | Maintains | $177 → $173 | +6.12% | Feb 20, 2025 |
Barclays | Barclays | Hold Maintains $166 → $160 | Hold | Maintains | $166 → $160 | -1.85% | Feb 20, 2025 |
Barclays | Barclays | Hold Maintains $205 → $166 | Hold | Maintains | $205 → $166 | +1.83% | Feb 18, 2025 |
Morgan Stanley | Morgan Stanley | Hold Maintains $220 → $184 | Hold | Maintains | $220 → $184 | +12.87% | Feb 5, 2025 |
Financial Forecast
Revenue This Year
3.95B
from 4.05B
Decreased by -2.49%
Revenue Next Year
4.18B
from 3.95B
Increased by 5.90%
EPS This Year
9.67
from 0.20
Increased by 4,733.70%
EPS Next Year
10.75
from 9.67
Increased by 11.23%
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 4.5B | 4.8B | 5.2B | ||
Avg | 3.9B | 4.2B | 4.7B | ||
Low | 3.7B | 3.9B | 4.5B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 10.3% | 21.0% | 23.5% | ||
Avg | -2.5% | 5.9% | 13.3% | ||
Low | -7.8% | -2.0% | 6.9% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 10.92 | 11.77 | 13.55 | ||
Avg | 9.67 | 10.75 | 13.03 | ||
Low | 8.84 | 9.80 | 12.64 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 5,360.0% | 21.8% | 26.0% | ||
Avg | 4,733.7% | 11.2% | 21.2% | ||
Low | 4,319.8% | 1.3% | 17.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.